BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26091253)

  • 1. Estimation and Short-Term Prediction of the Course of the HIV Epidemic Using Demographic and Health Survey Methodology-Like Data.
    Blaizot S; Riche B; Maman D; Mukui I; Kirubi B; Etard JF; Ecochard R
    PLoS One; 2015; 10(6):e0130387. PubMed ID: 26091253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of 90-90-90 on HIV-1 incidence and mortality in eSwatini: a mathematical modelling study.
    Akullian A; Morrison M; Garnett GP; Mnisi Z; Lukhele N; Bridenbecker D; Bershteyn A
    Lancet HIV; 2020 May; 7(5):e348-e358. PubMed ID: 32061317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of epidemic projections using recent HIV survey data in South Africa: a validation analysis of ten mathematical models of HIV epidemiology in the antiretroviral therapy era.
    Eaton JW; Bacaër N; Bershteyn A; Cambiano V; Cori A; Dorrington RE; Fraser C; Gopalappa C; Hontelez JA; Johnson LF; Klein DJ; Phillips AN; Pretorius C; Stover J; Rehle TM; Hallett TB
    Lancet Glob Health; 2015 Oct; 3(10):e598-608. PubMed ID: 26385301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for HIV infection in a national adult population: evidence from the 2003 Kenya Demographic and Health Survey.
    Johnson K; Way A
    J Acquir Immune Defic Syndr; 2006 Aug; 42(5):627-36. PubMed ID: 16868500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the contribution of key populations towards the spread of HIV in Dakar, Senegal.
    Mukandavire C; Walker J; Schwartz S; Boily MC; Danon L; Lyons C; Diouf D; Liestman B; Diouf NL; Drame F; Coly K; Muhire RSM; Thiam S; Diallo PAN; Kane CT; Ndour C; Volz E; Mishra S; Baral S; Vickerman P
    J Int AIDS Soc; 2018 Jul; 21 Suppl 5(Suppl Suppl 5):e25126. PubMed ID: 30033604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV incidence in western Kenya during scale-up of antiretroviral therapy and voluntary medical male circumcision: a population-based cohort analysis.
    Borgdorff MW; Kwaro D; Obor D; Otieno G; Kamire V; Odongo F; Owuor P; Muthusi J; Mills LA; Joseph R; Schmitz ME; Young PW; Zielinski-Gutierrez E; De Cock KM
    Lancet HIV; 2018 May; 5(5):e241-e249. PubMed ID: 29650451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PrEP for key populations in combination HIV prevention in Nairobi: a mathematical modelling study.
    Cremin I; McKinnon L; Kimani J; Cherutich P; Gakii G; Muriuki F; Kripke K; Hecht R; Kiragu M; Smith J; Hinsley W; Gelmon L; Hallett TB
    Lancet HIV; 2017 May; 4(5):e214-e222. PubMed ID: 28233660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemic impacts of a community empowerment intervention for HIV prevention among female sex workers in generalized and concentrated epidemics.
    Wirtz AL; Pretorius C; Beyrer C; Baral S; Decker MR; Sherman SG; Sweat M; Poteat T; Butler J; Oelrichs R; Semini I; Kerrigan D
    PLoS One; 2014; 9(2):e88047. PubMed ID: 24516580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National trends in HIV pre-exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017.
    Sullivan PS; Sanchez TH; Zlotorzynska M; Chandler CJ; Sineath RC; Kahle E; Tregear S
    J Int AIDS Soc; 2020 Mar; 23(3):e25461. PubMed ID: 32153119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.
    Koss CA; Havlir DV; Ayieko J; Kwarisiima D; Kabami J; Chamie G; Atukunda M; Mwinike Y; Mwangwa F; Owaraganise A; Peng J; Olilo W; Snyman K; Awuonda B; Clark TD; Black D; Nugent J; Brown LB; Marquez C; Okochi H; Zhang K; Camlin CS; Jain V; Gandhi M; Cohen CR; Bukusi EA; Charlebois ED; Petersen ML; Kamya MR; Balzer LB
    PLoS Med; 2021 Feb; 18(2):e1003492. PubMed ID: 33561143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Estimation and Projection Package Age-Sex Model and the r-hybrid model: new tools for estimating HIV incidence trends in sub-Saharan Africa.
    Eaton JW; Brown T; Puckett R; Glaubius R; Mutai K; Bao L; Salomon JA; Stover J; Mahy M; Hallett TB
    AIDS; 2019 Dec; 33 Suppl 3(Suppl 3):S235-S244. PubMed ID: 31800403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current drivers and geographic patterns of HIV in Lesotho: implications for treatment and prevention in Sub-Saharan Africa.
    Coburn BJ; Okano JT; Blower S
    BMC Med; 2013 Oct; 11():224. PubMed ID: 24131484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the impact on HIV incidence of combination prevention strategies among men who have sex with men in Beijing, China.
    Lou J; Blevins M; Ruan Y; Vermund SH; Tang S; Webb GF; Shepherd BE; He X; Lu H; Shao Y; Qian HZ
    PLoS One; 2014; 9(3):e90985. PubMed ID: 24626165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya.
    Nyabuti MN; Petersen ML; Bukusi EA; Kamya MR; Mwangwa F; Kabami J; Sang N; Charlebois ED; Balzer LB; Schwab JD; Camlin CS; Black D; Clark TD; Chamie G; Havlir DV; Ayieko J
    PLoS One; 2021; 16(2):e0243167. PubMed ID: 33544717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined interventions to reduce HIV incidence in KwaZulu-Natal: a modelling study.
    Blaizot S; Huerga H; Riche B; Ellman T; Shroufi A; Etard JF; Ecochard R
    BMC Infect Dis; 2017 Jul; 17(1):522. PubMed ID: 28747167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A general HIV incidence inference scheme based on likelihood of individual level data and a population renewal equation.
    Mahiane GS; Ouifki R; Brand H; Delva W; Welte A
    PLoS One; 2012; 7(9):e44377. PubMed ID: 22984497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the impact of HIV prevention and treatment for men who have sex with men on HIV epidemic trajectories in low- and middle-income countries.
    Wirtz AL; Walker DG; Bollinger L; Sifakis F; Baral S; Johns B; Oelrichs R; Beyrer C
    Int J STD AIDS; 2013 Jan; 24(1):18-30. PubMed ID: 23512511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual and community-level benefits of PrEP in western Kenya and South Africa: Implications for population prioritization of PrEP provision.
    Mudimu E; Peebles K; Mukandavire Z; Nightingale E; Sharma M; Medley GF; Klein DJ; Kripke K; Bershteyn A
    PLoS One; 2020; 15(12):e0244761. PubMed ID: 33382803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in Reversing the HIV Epidemic through Intensified Access to Antiretroviral Therapy: Results from a Nationally Representative Population-Based Survey in Kenya, 2012.
    Kim AA; Mukui I; N'gan'ga L; Katana A; Koros D; Wamicwe J; De Cock KM;
    PLoS One; 2016; 11(3):e0148068. PubMed ID: 26930291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.